NPS Pharmaceuticals is engaged in the discovery, development, and commercialization of therapeutic small molecules and recombinant proteins to treat bone, gastrointestinal, and CNS disorders More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Displaying 1..10 of 37 -
per page
Next page
Order by